From 2000 to 2002, several major advances, such as early goal-directed therapy (EGDT) [21], recombinant human activated protein C [6] and corticosteroid therapy [22], were introduced as part of the treatments used for severe sepsis and these may have produced some improvement in survival. The gene discussed is PROC; the disease is Sepsis.